Iron Therapy in Erythropoietic Protoporphyria

Oral Iron Therapy in Erythropoietic Protoporphyria

Giving oral iron to patients with erythropoietic protoporphyria (EPP) who is iron deficient is thought to be beneficial. This is, however, not well documented. The purpose of this study is to investigate the effect and safety of oral iron in patients with EPP who is taking iron tablets due to iron deficiency.

Inclusion Criteria:

• Diagnosed with EPP
• Taking standard dose of iron tablets due to iron deficiency

Exclusion Criteria:

• Pregnant
• Lactating